To sum up, the above results confirmed the findings we discovered based on the public data, demonstrating that GSTM2 were lower expressed in colon cancer tissues versus normal tissues and its expression were potentially relevant to the patient prognosis (OS). The gene discussed is GSTM2; the disease is malignant colon neoplasm.